Abstract:Introduction: Glutamine, the most abundant non-essential amino acids in circulation, serves as an important energy source in proliferating cells. Previous evidence has indicated that glutamine is not a primary carbon source for the tricarboxylic acid cycle in cardiomyocytes under physiological workload. However, current clinical studies reveal that impaired glutaminolysis is associated with heart failure and an increased risk of cardiovascular events. Hypothesis: We hypothesized that impaired glutaminolysis would compromise cardiac function, especially under conditions of increased workload. Methods: We analyzed cardiac structure and function in a mouse model with cardiac-specific knockdown of glutaminase (GLS), a key enzyme of glutaminolysis. Cardiac reserve was assessed by isoproterenol stress echocardiography. We performed transcriptomic, 13 C isotopic labeling, and reactive oxygen species emission analyses to investigate the underlying mechanism. Results: GLS deficiency impaired cardiac reserve and exercise capacity in mice, but had no discernible effects on cardiac structure or function under baseline condition. Inhibition of glutaminolysis in pressure-overloaded hearts further exacerbated cardiac dysfunction, indicating the critical role of glutaminolysis in cardiomyocytes under high workload. Mechanistically, glutaminolysis maintained cardiomyocyte function by balancing intracellular redox status through the production of glutathione (GSH), particularly in mitochondria. Inhibition of glutaminolysis decreased both cytosolic and mitochondrial GSH levels, resulting in compromised cell contraction in isolated cardiomyocytes under high workload. Additionally, heterologous expression of an engineered mitochondrial GSH biosynthetic enzyme increased mitochondrial GSH levels and enhanced cardiac reserve in GLS knockout mice. Conclusions: Our findings establish the previously unrecognized role of glutaminolysis in cardiomyocytes, maintaining cardiac reserve via upregulating mitochondrial GSH levels. This suggests that targeting glutaminolysis is a potential strategy for improving cardiac reserve and managing cardiac diseases.

In-depth Characterization of S-Glutathionylation in Ventricular Myosin Light Chain 1 Across Species by Top-Down Proteomics

GSTM2 Alleviates Heart Failure by Inhibiting DNA Damage in Cardiomyocytes.

Identification of S-glutathionylation Sites in Species-Specific Proteins by Incorporating Five Sequence-Derived Features into the General Pseudo-Amino Acid Composition.

PROTEOMICS – Clinical Applications Table of Contents

Deciphering modifications in swine cardiac troponin I by top-down high-resolution tandem mass spectrometry

Integrated Glycoprotein Immobilization Method for Glycopeptide and Glycan Analysis of Cardiac Hypertrophy.

Abstract 13835: Glutaminolysis Boosts Cardiac Performance Under High Workload via Enhancement of Mitochondrial GSH

A proteomic study of S-nitrosylation in the rat cardiac proteins in vitro.

S-glutathionylation Proteome Profiling Reveals a Crucial Role of a Thioredoxin-Like Protein in Interspecies Competition and Cariogenecity of Streptococcus Mutans

The Role of S-Glutathionylation in Health and Disease: A Bird's Eye View

Skeletal Muscle Aldolase an Overexpression in Endotoxemic Rats and Inhibited by GSNO Via Potential Role for S-nitrosylation in Vitro.

Valosin-containing protein acts as a target and mediator of S-nitrosylation in the heart through distinct mechanisms

Positive Regulation of Interleukin-1β Bioactivity by Physiological ROS-Mediated Cysteine S-Glutathionylation.

Glycan Imaging in Intact Rat Hearts and Glycoproteomic Analysis Reveal the Upregulation of Sialylation During Cardiac Hypertrophy.

Identification of Phosphorylation and Other Post-Translational Modifications in the Central C4C5 Domains of Murine Cardiac Myosin Binding Protein C

S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding

Molecular Basis and Structural Insight of Vascular KATP Channel Gating by S-Glutathionylation

Combination of FASP and fully automated 2D-LC-MS/MS allows in-depth proteomic characterization of mouse zymogen granules.

The Glycoproteomics–MS for Studying Glycosylation in Cardiac Hypertrophy and Heart Failure

Characterization of Potentials-Nitrosylation Sites in the Myocardium

Deep Learning Based Prediction of Species-Specific Protein S-glutathionylation Sites.